Andreas Maetzel Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

Andreas Maetzel is Senior Vice President, Medical of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of KALV, which is worth approximately $0. The most recent transaction as insider was on Apr 29, 2021, when has been sold 40,886 shares (Common Stock) at a price of $25.04 per share, resulting in proceeds of $1,023,785. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Andreas Maetzel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 29 2021	SELL Open market or private sale	$1,023,785 $25.04 p/Share	40,886 Reduced 100.0%	0 Common Stock
Apr 29 2021	BUY Exercise of conversion of derivative security	$438,707 $10.73 p/Share	40,886 Added 50.0%	40,886 Common Stock
Apr 28 2021	SELL Open market or private sale	$920,877 $25.49 p/Share	36,127 Reduced 100.0%	0 Common Stock
Apr 28 2021	BUY Exercise of conversion of derivative security	$285,765 $7.91 p/Share	36,127 Added 50.0%	36,127 Common Stock
Apr 27 2021	SELL Open market or private sale	$284,128 $25.79 p/Share	11,017 Reduced 100.0%	0 Common Stock
Apr 27 2021	BUY Exercise of conversion of derivative security	$87,144 $7.91 p/Share	11,017 Added 50.0%	11,017 Common Stock

Andreas Maetzel

Senior Vice President, Medical

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Value

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

Operation

Value

Type

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV

Account